Benchmarked against 500+ leading Indian startups.
Score my policyThis agent is most useful when your liquidity event is close and you already have clarity on your current share price.
In India, ESOPs face a dual-stage taxation framework: first upon allotment post-exercise, and again upon final sale. At the exercise stage, the difference between the Fair Market Value (FMV) and strike price is taxed at your income-tax slab (perquisite tax). When you eventually sell, the subsequent appreciation over that baseline FMV triggers Capital Gains tax.
Example: Priya's strike is ₹20 and the shares are ₹100 when she exercises — so (₹100 − ₹20) = ₹80 is the share value on which perquisite tax is applicable, taxed at her income-tax slab. She holds and sells at ₹150, so the later (₹150 − ₹100) = ₹50 is taxed as capital gains.
Perquisite tax is charged at your slab (30% + 4% cess = 31.2%) on your gain at exercise. Capital gains are 12.5% if held over 12 months, else 20%.
We'll run your numbers through perquisite tax, capital-gains tax and financing — then show both paths side by side.
Your ESOPs get taxed at two moments — once when you buy the shares (exercise), and again when you sell them. Understanding these two moments is the whole game, because when you exercise decides how much lands in the cheaper bucket.
The day you exercise, the gap between the share's value and the price you pay is treated as a bonus on your payslip — a perquisite — and taxed at your income slab.
Buy a share worth ₹300 for your ₹50 strike → ₹250 is added to your salary and taxed at your slab.
When you finally sell, you've already been taxed on the value at exercise. So only the extra gain on top is taxed again — usually at a much lower rate.
That share grows from ₹300 to ₹700 → only the ₹400 gain is taxed here, at 12.5% if held over a year.
Price is low, so only a small slice is taxed as salary. Most of your upside grows as capital gains — taxed lower. The trade-off: you pay (or finance) the cost now and carry it until you sell.
You wait, so the whole gain is taxed as salary at your slab — the higher rate. But there's nothing to pay or finance until you're ready to sell.
Benchmarked against 500+ leading Indian startups.
Score my policyModelled on dilution and funding paths of real companies.
See my numberBuilt on how exercise and sale are actually taxed in India.
Plan my taxWhen should I exercise my ESOP is the wrong first question, the right one is whether you can afford the perquisite tax on exercise without needing the shares to be liquid yet, since that tax is due at exercise regardless of whether you can sell. This planner compares exercising now against waiting, factoring in whether you should exercise ESOPs before an IPO, the post termination exercise window if you're leaving the company, and financing options like ESOP loans if the tax bill outpaces your cash on hand. It runs the cash versus ESOP trade off across timelines so you're not guessing at an ESOP exercise strategy under a ticking clock, weighing the risk of exercising early into an illiquid, uncertain stock against the risk of running out of time to exercise at all. You'll also see how to reduce tax on ESOP sale through timing choices like crossing the 12 or 24 month LTCG threshold before you sell. The output is a planning estimate based on your inputs and current tax rules, not a recommendation, so confirm timing decisions with a tax professional before you exercise.
This tool is provided by Dezerv for educational and illustrative purposes only. It is intended to help you structure conversations around your finances and does not constitute investment, tax, legal or financial advice, or any recommendation, offer or solicitation to buy/sell any security or adopt any investment strategy. The outputs generated are estimates based on the information and inputs provided by you and use simplified, editable assumptions. They should not be relied upon as a substitute for professional advice. Before taking any action based on the information provided, please consult your legal, tax and financial advisors. While reasonable care has been taken to present reliable data, Dezerv does not guarantee the accuracy or completeness or suitability of the information presented and shall not be responsible or liable for any decisions, actions or omissions based on or arising such information.